 Now, perhaps the most significant decisions made by the court during this term actually had to do with next term. First, the court declined to hear FDA versus the Alliance for Hippocratic Medicine, a case that challenged how the FDA under the Biden administration loosened regulations for mifepristone, the drug used in chemical abortions.